Zevra Therapeutics (ZVRA) Selling, General & Administrative (2014 - 2026)
Zevra Therapeutics (ZVRA) recorded Selling, General & Administrative of $16.56 million in Q2 2026, down 20.3% from $20.78 million a year earlier and down 20.3% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Selling, General & Administrative (2014 - 2026) Analysis & Trends
On a TTM basis, Zevra Therapeutics' Selling, General & Administrative came in at $74.63 million as of Jun 30, 2026, up 2.7% year-over-year; for FY2025, it was $77.62 million, up 41.5% from FY2024.
- Annual Selling, General & Administrative has increased for five straight years, with a five-year compound annual growth rate of 57.8% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $54.87 million in FY2024 (+59.9%), $34.31 million in FY2023 (+128.2%), $15.04 million in FY2022 (+72.8%) and $8.7 million in FY2021 (+9.8%).
- The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q4 2024.
- On a year-over-year basis, Selling, General & Administrative rose in seven of the last eight quarters, with growth averaging 45.9%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 207.1% in Q4 2023, against a decline of 20.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $20.78 million (Q1 2026), $20.35 million (Q4 2025) and $16.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 16.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.56 Mn |
| Mar 31, 2026 | 20.78 Mn |
| Dec 31, 2025 | 20.35 Mn |
| Sep 30, 2025 | 16.94 Mn |
| Jun 30, 2025 | 20.78 Mn |
| Mar 31, 2025 | 19.55 Mn |
| Dec 31, 2024 | 16.13 Mn |
| Sep 30, 2024 | 16.21 Mn |
| Jun 30, 2024 | 12.60 Mn |
| Mar 31, 2024 | 9.93 Mn |
| Dec 31, 2023 | 14.66 Mn |
| Sep 30, 2023 | 5.82 Mn |
| Jun 30, 2023 | 6.61 Mn |
| Mar 31, 2023 | 7.23 Mn |
| Dec 31, 2022 | 4.77 Mn |
| Sep 30, 2022 | 3.97 Mn |
| Jun 30, 2022 | 3.56 Mn |
| Mar 31, 2022 | 2.73 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 1.95 Mn |
API Access
Zevra Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();